Lessons from a 125-Year-Old Family Business

In 1899, when Vaidya D. K. Sandu set up a small Ayurvedic dispensary, the world looked very different. Queen Victoria was on the throne. The car had just been invented. India would not see independence for nearly half a century. And yet the company that began that year — Sandu Pharmaceuticals — is still standing today, four generations later.

I am often asked what it is like to work inside an institution older than most countries' constitutions. The honest answer is that it is less romantic and more humbling than people imagine. A 125-year-old family business does not survive by accident. It survives by absorbing lesson after lesson, generation after generation, and refusing to confuse longevity with permanence.

What Sandu has lived through

To understand the weight of a 125-year legacy, it helps to list what it has outlasted. Two world wars. The 1918 flu pandemic. India's independence and partition. The license raj. Liberalisation. The dot-com boom and bust. The 2008 financial crisis. COVID-19. The arrival of e-commerce, the smartphone, the rise of D2C, and the AI revolution.

Each of those events killed companies that were healthier and bigger at the time. So why is Sandu still here? Not because we did anything magical. Because four generations made a series of unsexy, deliberate choices. Here are the five that have mattered most.

Lesson 1: A mission is the only real moat

Products go in and out of fashion. Categories rise and fall. The only thing that compounds across generations is a clear, durable purpose.

For Sandu, that purpose has been Ayurveda — not as a marketing label, but as a discipline. We do not chase trends. We do not pivot when a new wellness category becomes hot. We deepen our commitment to the science we were founded on, even when the market is impatient. Ironically, that patience is what has made the brand more valuable, not less.

The wellness boom and the temptation to dilute

In the last decade, “Ayurveda” has become a marketing category. Brands spring up overnight with herbal positioning and shoestring R&D. The temptation to compete on their terms is real. Resisting that temptation — staying anchored to clinical rigour and traditional formulations — has been one of the harder choices, and one of the more important ones.

Lesson 2: Generational humility

The most dangerous thing a fourth-generation leader can do is assume the previous three got it wrong. They didn't. They were navigating their own constraints with information you don't have.

I have learned to read the archives before I rewrite the playbook. The answer to most strategic questions is somewhere in a meeting note from forty years ago. Generational humility means earning the right to change something by first understanding why it exists.

Every generation inherits a building. Some inherit a temple. The work is to know the difference — and to never confuse renovation with demolition.

Lesson 3: Conservative balance sheets are a feature, not a bug

Family businesses that survive a century are almost always financially conservative. Not because they lack ambition, but because they understand that an ambitious decade can be erased by a careless one.

We borrow carefully. We invest in inventory and infrastructure that compounds. We say no to capital that comes with strings we cannot accept. In a venture-capital-saturated era, this can look quaint. It is not. It is the reason we are still around to be quaint.

Lesson 4: Community is the customer

For most of Sandu's history, our most loyal customers have not been retail buyers. They have been Ayurvedic practitioners — vaidyas, doctors of Ayurveda, integrative health professionals — who recommended our formulations to their patients because they trusted the chemistry.

Treating practitioners as a community rather than a sales channel changed how we showed up. We hosted workshops. We supported research. We listened to feedback that no quarterly review would ever surface. In return, they gave us something no marketing budget could buy: a network of credible voices who chose us, freely, because we had earned it.

Lesson 5: Compliance is a catalyst, not a cost

Pharmaceutical companies — especially traditional ones — often treat compliance as overhead. We have come to see it differently. Every audit, every regulatory tightening, every quality requirement is a forcing function that makes the next generation of the business stronger than the last.

As Legal Counsel, I have watched governance shifts that felt painful at the time become competitive advantages five years later. The companies that complain about compliance are usually the ones that needed it most. The companies that build for the rules of 2030 today are the ones that will still be here in 2040.

The fourth generation question

Every family business eventually faces the same question: what does it mean to be the fourth generation of something you didn't start? It is a question I think about often.

The honest answer is that you are not really the fourth generation of the business. You are the fourth generation of a conversation. Your job is not to preserve the company in amber. Your job is to keep the conversation alive — between the founders' intent and the present moment, between what cannot change and what must.

That conversation is what has carried Sandu through 125 years. And if we do our work well — if we are humble enough to listen and bold enough to act — it is what will carry the company through the next 125.

For founders building today

If you are building a company right now — a startup, a brand, an institution — and you have ambitions that extend beyond your own career, the lessons of a 125-year-old company are worth your attention.

• Decide what cannot change. Defend it like a religion.
• Decide what must keep changing. Touch it like a sculptor.
• Be financially conservative in private so you can be bold in public.
• Treat compliance as architecture, not paperwork.
• Build for a community, not a transaction.

Legacy is not a noun. It is a verb. It is the daily, unglamorous act of showing up for an idea that is older than you, and trusting that the next generation will do the same.